FDA Rubber-Stamps Remdesivir for Infants Without Evidence of Safety, Efficacy
by Madhava Setty, M.D., Childrens Health Defense: The U.S. Food and Drug Administration on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants 4 weeks and older, despite having no evidence […]